Reposted by @ericvivier.bsky.social
🧬 Which solid tumours should NK cell therapies target? Tissue analysis, a review of 177 trials and >10,000 TCGA samples offer a framework for prioritisation @ericvivier.bsky.social
pmc.ncbi.nlm.nih.gov/articles/PMC...
#NKcells #Immunotherapy
pmc.ncbi.nlm.nih.gov
A Multimodal Framework to Guide Solid Tumor Indications for Natural Killer Cell‐Based Therapy
T cell‐based immunotherapies have achieved remarkable success in hematological malignancies but remain limited in solid tumors. Natural killer (NK) cells offer a compelling complementary approach, giv...
